Qiagen Overview
Company Headquarters: Germany, Europe
Founded: 1984
Workforce: 5,000
Company Working: Qiagen is a healthcare company that deals in sample and assay technologies for molecular diagnostics. The company operates through more than 35 offices spread in over 25 countries. It serves more than 500,000 customers across the globe. Its product portfolio spans through a full range of molecular testing applications. Qiagen’s products are used for extraction, purification, and stabilization of DNA, RNA, and protein from various biological samples. It has over 500 core products in its portfolio. The company is listed on the New York Stock and Frankfurt Prime Standard exchanges. It offers its products in various areas such as discovery & translational research, diagnostics & clinical research, next-generation sequencing, and instruments & automation.
Strategy
Qiagen focuses on increasing its presence in key emerging markets such as Brazil, Russia, India, China, South Korea, Mexico, and Turkey. It also focuses on launching innovative, differentiated, and high-quality products to address the unmet medical and scientific needs. Moreover, its long-term business strategy is to enter into strategic alliances as well as marketing and distribution agreements to expand in the global market.
